Skip to main contentSkip to navigation
Sirius Investors
Primo Nutraceuticals Inc.

Primo Nutraceuticals Inc.

BUGVF
OTC•Healthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for BUGVF. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Quick links:Overview•Financial Metrics•Technicals•Returns•Financials•Performance

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
6.75M
N/A over period

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
7.35M
N/A over period

Market Cap History

Investor Valuation Insights

As of Apr 30, 2020

EV/EBITDA

Distorted

-19.77x

Negative EV/EBITDA usually means negative EBITDA; compare with revenue and cash flow metrics.

EV vs Market Cap Spread

595.45K

EV is +8.8% vs equity value

Capital Structure Signal

Net Debt Profile

Trend unavailable for selected history

Additional Multiples

EV/Sales: 0.00x

Net Debt/EBITDA: -3.46x

Share count trend unavailable

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Jul 31, 20196.75M7.35M$1.544.38M
Jul 31, 20186.53M6.53M$1.584.12M
Jul 31, 20176.26M6.50M$1.524.12M
Jul 31, 2016
————

Enterprise Value Analysis

Price Change (Jul 2018 to Jul 2019)

The stock price has decreased from Jul 2018 to Jul 2019.
-2.53%

Recent Volatility

The stock price has been relatively stable over the last 3 periods, indicating a lower risk profile.
0.03

Risk-Adjusted Return

The stock's returns compensate somewhat for its risk, suggesting a moderate investment opportunity.
0.22

Market Cap Change (Jul 2018 to Jul 2019)

The company's market capitalization has increased from Jul 2018 to Jul 2019.
+3.38%

Enterprise Value Change (Jul 2018 to Jul 2019)

The company's enterprise value has increased from Jul 2018 to Jul 2019, suggesting growth in the company's total economic value.
+12.51%

Market Cap vs. Enterprise Value

A higher enterprise value growth rate compared to market cap growth could indicate that the company is investing heavily in growth initiatives or taking on more debt.
EV Growth > Market Cap Growth

Market Cap CAGR

The Compound Annual Growth Rate (CAGR) of market capitalization represents the mean annual growth rate over the entire available history (3 periods), accounting for compounding effects.
3.80%

Enterprise Value CAGR

The Compound Annual Growth Rate (CAGR) of enterprise value represents the mean annual growth rate over the entire available history (3 periods), accounting for compounding effects.
6.31%